News
When it comes to cutting-edge health technology, Jecizer Biosciences is quickly becoming the name you’ve probably haven’t ...
Life X DNA™, an Australia-based provider of advanced DNA analysis, has announced the availability of its genetic methylation testing in Canberra services in Canberra, ACT. The company’s at-home test ...
13d
Medical Device Network on MSNIllumina bets on proteomics with $425m SomaLogic purchaseIllumina expects the addition of a high-margin revenue stream, although the deal is expected to close in 2026.
When it comes to storing images, DNA strands could be a sustainable, stable alternative to hard drives. Researchers at EPFL ...
This partnership brings patients one step closer to faster, safer, and more effective treatment options guided by their genetic profile.” — Zachary Brooks, PhD, founder and CEO of UGenome AI ...
The majority of patients with the most common advanced or metastatic cancers in the United States do not undergo ...
Market is expected to reach at a CAGR of 11.6% during the forecast period 2025-2033. The Next Generation Sequencing (NGS) ...
Next Generation Sequencing Market Research, 2035 The global next generation sequencing market is projected to reach $97.8 billion by 2035, ...
The advent of next-generation sequencing has made possible genome analysis at previously unattainable depth. Roche, Illumina and Life Technologies, among others, have developed well-established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results